InsiderTrades

GC Cell Corp

SEC CIK 1931891 · EDGAR

Buying vs selling by month open-market trades, last 27 months, ARTV
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ARTVArtiva Biotherapeutics, Inc.10% 1.26M $25.00M — 62024-07-222024-07-22

Most active insiders at ARTV, 12 months

#InsiderTitleBoughtSold
1 RA CAPITAL MANAGEMENT, L.P.Dir, 10% $92.68M—
2 GC Corp.10% $16.50M—
3 Aslan FredPres, CEO, Dir —$1.38M
4 Banerjee SubhashisChief Medical Off —$179.5K
5 Horan ChristopherChief Tech Ops Off —$178.7K
6 Bush JenniferCOO, CLO, Secy, Compliance Off —$172.8K
7 Raymon HeatherSVP, Research, Development —$27.9K
8 Krishnamohan NehaCFO ——
9 Miralles Gines DiegoPres, Head of R, D ——
10 Huston Thad AllenCFO ——

GC Cell Corp made no open-market trades at ARTV in the last 12 months.

Transactions 6

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
DI 2024-07-22 2024-07-22 ARTV Artiva Biotherapeutics, Inc. GC Cell Corp 10% P - Purchase $12.00 +416.7K 1.26M +49% +$5.00M
DI 2024-07-22 2024-07-22 ARTV Artiva Biotherapeutics, Inc. GC Cell Corp 10% J - Other $10.20 +256.3K 843.8K +44% +$2.61M
DMI 2024-07-22 2024-07-22 ARTV Artiva Biotherapeutics, Inc. GC Cell Corp 10% C - Cnv Deriv — +355.0K 525.3K +208% —
D 2024-07-22 2024-07-22 ARTV Artiva Biotherapeutics, Inc. GC Cell Corp 10% P - Purchase $12.00 +1.67M 3.31M +102% +$20.00M
D 2024-07-22 2024-07-22 ARTV Artiva Biotherapeutics, Inc. GC Cell Corp 10% J - Other $10.20 +294.1K 1.64M +22% +$3.00M
DM 2024-07-22 2024-07-22 ARTV Artiva Biotherapeutics, Inc. GC Cell Corp 10% C - Cnv Deriv — +997.3K 1.02M +5,321% —

Purchase Sale Sale after option exercise All abbreviations